Indian Journal of Public Health Research & Development

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Incidence of Metabolic Syndrome and Diabetes Mellitus in Raipur City of Chattishgarh State-a Preliminary Study


Affiliations
1 School of Studies in Biochemistry, Jiwaji University, Gwalior-474 011, India
2 Ravishankar Shukla University, Raipur, India
3 School of Studies in Biochemistry, Jiwaji University, Gwalior, Madhya Pradesh, India
4 RFCL, Okhla Industrial area, New Delhi, India
5 School of Studies in Biochemistry & Biotechnology, Jiwaji University Gwalior, Madhya Pradesh, India
6 School of Studies in Biochemistry & Biotechnology, Jiwaji University, Gwalior, India
     

   Subscribe/Renew Journal


Metabolic syndrome (MS) is a cluster of metabolic abnormalities and serves as a precursor of cardiovascular disorders (CVD). The objective of the study was to determine the prevalence of MS and its association with Diabetes mellitus (DM) in an urban setup of Raipur city of Chattishgarh State. A cross sectional study was conducted on 400 randomly selected subjects (men 186, women 214 of age group 10-80 years) in the study region. Anthropometric variables, blood pressure, and lipid profile were monitored besides blood glucose in the study population. The incidence of MS and DM were worked out as per the criteria of National Cholesterol Education Programme-ATPIII (NCEPATPIII) and World Health Organization.The incidence of MS was found to be 15% and 5% by ATPIII and WHO criteria respectively. According to NCEP-ATPIII criterion, women recorded significantly high incidence of MS (65%) as compared to males (35%). About 28% of subjects with MS exhibited type II DM (males 16.6% and females 11.6%). On the other hand, the incidence of type II DM was found to be 6.7% in non-metabolic syndrome group of subjects as per NCEP-ATPIII criterion. By WHO criteria, 65% of the subjects with MS exhibited type II DM (males 35% and females 30%) while the incidence is 6.9% in non-metabolic syndrome group of subjects. Subjects in age group of 41-65 years showed the highest incidence of MS irrespective of the criteria employed. The incidence of MS differed significantly by the two criteria employed and it was more by NCEP-ATP-III criteria. The prevalence of type II DM was significantly high in subjects with metabolic syndrome and it was more in males of age group of 41-65 yrs.

Keywords

Diabetes Mellitus, Metabolic Syndrome (MS), Hyperlipidemia, Hyperglycemia, Blood Pressure
Subscription Login to verify subscription
User
Notifications
Font Size


  • Alberti KG, Zimmet P, Shaw J: The metabolic syndrome—a new worldwide definition. Lancet 2005; 366:1059-1062.

  • Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41:715-722.

  • Isomaa B, Almgren P, Tiinamaija T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome. Diabetes Care 2001; 24:683-689.

  • Wang J, Thornton JC, Heymsfield SB, Pierson RN Jr. The relationship between body mass index and body cell mass in African-American, Asian, and Caucasians adults. Acta Diabetol. 2003; 40:305-308.

  • King H, Aubert RE, Herman WH. Global burden of diabetes 1995-2025: prevalence, numerical, estimates, and projection. Diabetes Care 1998 ;21:1414-31.

  • Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999; 84:2329-2335.

  • Joshi SR. Metabolic Syndrome-emerging clusters of the Indian phenotype. J Assoc Physicians India 2003; 51:445-446.

  • Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349:1269-1276.

  • Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286:1195-2000.

  • Martin Briner, Erik Erikson page, 1999, on Briner’s site about learning theories, USMA Department of Mathematical Sciences, Center for Assessment and Program Evaluation (CAPE), United States Military Academy at West Point. Accessed 24 November 2006.

  • Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Annal Clin Biochem 1969; 6: 24-27.

  • Deeg R, Ziegenhorn J. Kinetic enzymatic method for automated determination of total cholesterol in serum. Clin Chem 1983; 29:1798-802.

  • Trinder P. Triglyceride estimation by GPO-PAP method. Ann Clin Biochem 1969; 6:24-7.

  • Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoprotein from human serum by precipitation with polyanions. J Lipid Res 1970; 11:583-7

  • American Diabetes Association Diagnosis and Classiûcation of Diabetes Mellitus Diabetes Care 2004; 27:S3-S10.

  • National Institutes of Health: Executive Summary. In Third Report of the National Cholestrol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholestrol in Adults (Adults Treatment Panel III), JAMA 2001; 285:2486- 2497.

  • Alberti KGMM, Zimmet PZ, for the WHO consultation. Definition, diagnosis and classification of diabetes mellitus and its complication. Part 1. Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998; 15:539-53.

  • Erbas T. Metabolic syndrome. Acta Diabetol 2003; 40:401-404.

  • Mancia G. The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction. Acta Diabetol 2005; 42:17-25.

  • Ghoddusi K, Ameli J, Kachuee H, Pourfarziani V, Saadat A, Karami Q. Association of diabetes mellitus and dyslipidaemias in the Tehran population. Eastern Mediterranean Health Journal 2008; 14:647-653.

  • Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001; 44:1094-1101.


Abstract Views: 384

PDF Views: 3




  • Incidence of Metabolic Syndrome and Diabetes Mellitus in Raipur City of Chattishgarh State-a Preliminary Study

Abstract Views: 384  |  PDF Views: 3

Authors

Dhananjay Yadav
School of Studies in Biochemistry, Jiwaji University, Gwalior-474 011, India
Shweta Tarar
Ravishankar Shukla University, Raipur, India
Neha Ghosh
School of Studies in Biochemistry, Jiwaji University, Gwalior, Madhya Pradesh, India
R P Tiwari
RFCL, Okhla Industrial area, New Delhi, India
P S Bisen
School of Studies in Biochemistry & Biotechnology, Jiwaji University Gwalior, Madhya Pradesh, India
G B K S Prasad
School of Studies in Biochemistry & Biotechnology, Jiwaji University, Gwalior, India

Abstract


Metabolic syndrome (MS) is a cluster of metabolic abnormalities and serves as a precursor of cardiovascular disorders (CVD). The objective of the study was to determine the prevalence of MS and its association with Diabetes mellitus (DM) in an urban setup of Raipur city of Chattishgarh State. A cross sectional study was conducted on 400 randomly selected subjects (men 186, women 214 of age group 10-80 years) in the study region. Anthropometric variables, blood pressure, and lipid profile were monitored besides blood glucose in the study population. The incidence of MS and DM were worked out as per the criteria of National Cholesterol Education Programme-ATPIII (NCEPATPIII) and World Health Organization.The incidence of MS was found to be 15% and 5% by ATPIII and WHO criteria respectively. According to NCEP-ATPIII criterion, women recorded significantly high incidence of MS (65%) as compared to males (35%). About 28% of subjects with MS exhibited type II DM (males 16.6% and females 11.6%). On the other hand, the incidence of type II DM was found to be 6.7% in non-metabolic syndrome group of subjects as per NCEP-ATPIII criterion. By WHO criteria, 65% of the subjects with MS exhibited type II DM (males 35% and females 30%) while the incidence is 6.9% in non-metabolic syndrome group of subjects. Subjects in age group of 41-65 years showed the highest incidence of MS irrespective of the criteria employed. The incidence of MS differed significantly by the two criteria employed and it was more by NCEP-ATP-III criteria. The prevalence of type II DM was significantly high in subjects with metabolic syndrome and it was more in males of age group of 41-65 yrs.

Keywords


Diabetes Mellitus, Metabolic Syndrome (MS), Hyperlipidemia, Hyperglycemia, Blood Pressure

References